OWC Pharmaceutical Research Corp. Stock Other OTC
Equities
OWCP
US67109N1081
Advanced Medical Equipment & Technology
Sales 2017 | - | Sales 2018 | - | Capitalization | 15.37M 21.02M |
---|---|---|---|---|---|
Net income 2017 | -4M -5.47M | Net income 2018 | -10M -13.68M | EV / Sales 2017 | - |
Net cash position 2017 | 971K 1.33M | Net cash position 2018 | 3.46M 4.74M | EV / Sales 2018 | - |
P/E ratio 2017 |
-14.5
x | P/E ratio 2018 |
-1.21
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ziv Turner
CEO | Chief Executive Officer | 52 | 20-06-20 |
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 14-06-15 |
Yehuda Baruch
CTO | Chief Tech/Sci/R&D Officer | 67 | 16-11-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 20-06-24 |
Ziv Turner
CEO | Chief Executive Officer | 52 | 20-06-20 |
Hannah Fayer
BRD | Director/Board Member | 69 | - |
1st Jan change | Capi. | |
---|---|---|
-42.86% | 2.85B | |
+20.51% | 1.94B | |
-1.13% | 1.68B | |
+27.00% | 1.26B | |
-14.07% | 1.03B | |
-20.60% | 938M | |
+0.88% | 783M | |
-24.34% | 628M | |
+8.73% | 535M |